Status:
COMPLETED
Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
This study is conducted in Europe. The aim of this observational study is to investigate the switch from metformin alone to metformin combined with repaglinide in type 2 diabetic patients not achievi...
Eligibility Criteria
Inclusion
- Type 2 diabetic patients with inadequate glycaemic control when received metformin alone on maximal dose
- Signed informed consent
- Treatment in accordance with the summary of product characterisation
Exclusion
- Any contraindication to metformin or repaglinide
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
2171 Patients enrolled
Trial Details
Trial ID
NCT00709917
Start Date
March 1 2007
End Date
January 1 2008
Last Update
March 3 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brussels, Belgium, 1070
2
Luxembourg, Luxembourg